Understanding the patterns of repeated testing for COVID-19: Association with patient characteristics and outcomes
Stephen Salerno, Zhangchen Zhao, Swaraaj Prabhu Sankar, Maxwell Salvatore, Tian Gu, Lars G. Fritsche, Seunggeun Lee, Lynda D. Lisabeth, Thomas S. Valley, Bhramar MukherjeemedRxiv2020 · DOI
During the initial wave of the COVID-19 pandemic, diagnostic testing patterns were influenced by both clinical necessity and systemic factors. This cross-sectional study analyzed 15,920 patients at Michigan Medicine between March and June 2020 to identify the characteristics associated with repeated testing. While 85.4% of patients were tested only once, a significant subset (14.6%) underwent multiple rounds of testing. Our findings indicate that repeated testing was significantly associated with specific comorbidities (particularly kidney and circulatory diseases), male sex, non-Hispanic Black race, and neighborhood poverty levels. Among patients who tested positive, hospitalization and ICU-level care were the strongest predictors of repeated testing, often driven by discharge protocols. Additionally, we estimated a "real-world" RT-PCR false negative rate of 23.8%, highlighting the clinical importance of serial testing in symptomatic individuals.
Introduction
Early in the COVID-19 pandemic, public health decisions relied heavily on case counts. However, these metrics are inherently biased by testing accessibility and frequency. Because RT-PCR diagnostic tests were known to have high false-negative rates, clinical guidelines often necessitated repeated testing to confirm a diagnosis or clear a patient for discharge. Understanding who receives multiple tests—and why—is crucial for interpreting epidemiological data and identifying potential disparities in healthcare delivery. This study examines the patterns of repeated testing at Michigan Medicine, a primary regional center during the first wave, to determine how patient characteristics and clinical outcomes influenced testing frequency.
Methods
The study utilized Electronic Health Records (EHR) from 15,920 patients who presented to Michigan Medicine for COVID-19 diagnostic testing between March 10 and June 4, 2020. To provide a comprehensive view of the patients' backgrounds, clinical data were linked with the National Neighborhood Data Archive (NaNDA), allowing researchers to account for neighborhood-level socioeconomic status (NSES), including poverty and education levels at the census tract level.
Statistical analysis involved multivariable logistic regression to determine the odds of a patient being tested more than once, adjusting for demographics and clinical history. For patients with at least one positive result, the study analyzed the relationship between repeated testing and severe outcomes like hospitalization and ICU admission. Furthermore, the researchers calculated an empirical false negative rate by identifying "sandwiched" test results—cases where a negative result occurred between two positive results for the same patient.
Key Findings
Demographic and Socioeconomic Drivers
Testing patterns revealed significant disparities across demographic and socioeconomic lines. Even after adjusting for health status, neighborhood poverty and race remained significant predictors of testing frequency:
Race: Non-Hispanic Black patients had 21% higher odds (OR: 1.21) of receiving repeated testing compared to non-Hispanic white patients.
Sex: Females were less likely to receive additional testing than males (OR: 0.86).
Socioeconomics: For every 1% increase in the proportion of the population living below the federal poverty level in a patient's neighborhood, the odds of receiving repeated testing increased by 1%.
Clinical Comorbidities
Pre-existing conditions were strong indicators of whether a patient would undergo multiple tests. Patients with the following conditions showed significantly higher odds of repeated testing:
Kidney Disease: OR 1.95
Circulatory Diseases: OR 1.42
Liver Diseases: OR 1.30
Type 2 Diabetes: OR 1.22
Cancer: OR 1.14
The "Discharge Hurdle" and Hospitalization
For the 1,167 patients who tested positive at least once, the strongest drivers for repeated testing were hospitalization (OR: 7.44) and ICU-level care (OR: 6.97). This pattern was largely a result of early-pandemic protocols, which required patients to produce two negative tests 24 hours apart before they could be safely discharged to congregate care settings, such as nursing homes or assisted living facilities. Interestingly, patients undergoing repeated testing experienced shorter average wait times for results (13.8 hours) compared to those tested once (22.2 hours), likely due to the prioritization of in-hospital laboratory processing.
Diagnostic Volatility and False Negatives
The study tracked "flips" in test results—instances where a patient's status switched from positive to negative or vice versa. While 89% of re-tested patients had consistent results, the remaining group experienced volatility that highlights the limitations of a single RT-PCR test. By analyzing these sequences, the researchers estimated a "real-world" false negative rate of 23.8%. This suggests that nearly one in four infected individuals may receive an incorrect negative result on a single test, justifying the clinical intuition to re-test symptomatic patients.
Discussion and Limitations
These results demonstrate that repeated testing is not random; it is a function of clinical severity, institutional protocols, and socioeconomic factors. The high false-negative rate observed underscores the necessity of serial testing in high-stakes clinical environments.
However, the study has limitations. As a single-center study at an academic medical center, the findings may reflect specific regional protocols that differ from rural or non-academic settings. Additionally, the EHR data only captures tests performed within the Michigan Medicine system, potentially missing tests conducted at external pharmacies or community drive-thru sites. Finally, the use of ICD codes to define comorbidities serves as a proxy for clinical state but may not capture the full nuance of a patient's health at the time of testing.
Conclusion
By decoding the patterns of repeated testing, this research provides a clearer lens through which to view pandemic data. The findings suggest that while clinical need (comorbidities and hospitalization) drove much of the re-testing, socioeconomic and demographic factors also played a role. As diagnostic technologies evolve, understanding these historical patterns remains vital for improving testing equity and diagnostic accuracy in future public health crises.
Summary updated
Abstract
Abstract Importance The diagnostic tests for COVID-19 have a high false negative rate, but not everyone with an initial negative result is re-tested. Michigan Medicine, being one of the primary regional centers accepting COVID-19 cases, provided an ideal setting for studying COVID-19 repeated testing patterns during the first wave of the pandemic. Objective To identify the characteristics of patients who underwent repeated testing for COVID-19 and determine if repeated testing was associated with patient characteristics and with downstream outcomes among positive cases. Design This cross-sectional study described the pattern of testing for COVID-19 at Michigan Medicine. The main hypothesis under consideration is whether patient characteristics differed between those tested once and those who underwent multiple tests. We then restrict our attention to those that had at least one positive test and study repeated testing patterns in patients with severe COVID-19 related outcomes (testing positive, hospitalization and ICU care). Setting Demographic and clinical characteristics, test results, and health outcomes for 15,920 patients presenting to Michigan Medicine between March 10 and June 4, 2020 for a diagnostic test for COVID-19 were collected from their electronic medical records on June 24, 2020. Data on the number and types of tests administered to a given patient, as well as the sequences of patient-specific test results were derived from records of patient laboratory results. Participants Anyone tested between March 10 and June 4, 2020 at Michigan Medicine with a diagnostic test for COVID-19 in their Electronic Health Records were included in our analysis. Exposures Comparison of repeated testing across patient demographics, clinical characteristics, and patient outcomes Main Outcomes and Measures Whether patients underwent repeated diagnostic testing for SARS CoV-2 in Michigan Medicine Results Between March 10th and June 4th, 19,540 tests were ordered for 15,920 patients, with most patients only tested once (13596, 85.4%) and never testing positive (14753, 92.7%). There were 5 patients who got tested 10 or more times and there were substantial variations in test results within a patient. After fully adjusting for patient and neighborhood socioeconomic status (NSES) and demographic characteristics, patients with circulatory diseases (OR: 1.42; 95% CI: (1.18, 1.72)), any cancer (OR: 1.14; 95% CI: (1.01, 1.29)), Type 2 diabetes (OR: 1.22; 95% CI: (1.06, 1.39)), kidney diseases (OR: 1.95; 95% CI: (1.71, 2.23)), and liver diseases (OR: 1.30; 95% CI: (1.11, 1.50)) were found to have higher odds of undergoing repeated testing when compared to those without. Additionally, as compared to non-Hispanic whites, non-Hispanic blacks were found to have higher odds (OR: 1.21; 95% CI: (1.03, 1.43)) of receiving additional testing. Females were found to have lower odds (OR: 0.86; 95% CI: (0.76, 0.96)) of receiving additional testing than males. Neighborhood poverty level also affected whether to receive additional testing. For 1% increase in proportion of population with annual income below the federal poverty level, the odds ratio of receiving repeated testing is 1.01 (OR: 1.01; 95% CI: (1.00, 1.01)). Focusing on only those 1167 patients with at least one positive result in their full testing history, patient age in years (OR: 1.01; 95% CI: (1.00, 1.03)), prior history of kidney diseases (OR: 2.15; 95% CI: (1.36, 3.41)) remained significantly different between patients who underwent repeated testing and those who did not. After adjusting for both patient demographic factors and NSES, hospitalization (OR: 7.44; 95% CI: (4.92, 11.41)) and ICU-level care (OR: 6.97; 95% CI: (4.48, 10.98)) were significantly associated with repeated testing. Of these 1167 patients, 306 got repeated testing and 1118 tests were done on these 306 patients, of which 810 (72.5%) were done during inpatient stays, substantiating that most repeated tests for test positive patients were done during hospitalization or ICU care. Additionally, using repeated testing data we estimate the “real world” false negative rate of the RT-PCR diagnostic test was 23.8% (95% CI: (19.5%, 28.5%)). Conclusions and Relevance This study sought to quantify the pattern of repeated testing for COVID-19 at Michigan Medicine. While most patients were tested once and received a negative result, a meaningful subset of patients (2324, 14.6% of the population who got tested) underwent multiple rounds of testing (5,944 tests were done in total on these 2324 patients, with an average of 2.6 tests per person), with 10 or more tests for five patients. Both hospitalizations and ICU care differed significantly between patients who underwent repeated testing versus those only tested once as expected. These results shed light on testing patterns and have important implications for understanding the variation of repeated testing results within and between patients. Key Points Question Does having repeated diagnostic tests for the novel coronavirus (COVID-19) depend on patient characteristics and disease outcomes? Findings This cross-sectional study of testing patterns with 15,920 patients tested for SARS-CoV-2 virus at Michigan Medicine found significant differences in testing rates across patient age, body mass index, sex, race/ethnicity, neighborhood poverty level, prior history of circulatory diseases, any cancer, Type 2 diabetes, kidney, and liver diseases. Higher hospitalization rates and intensive care unit admissions were associated with repeated testing as expected. Meaning The results of this study describe diagnostic testing patterns for the novel COVID-19 virus at Michigan Medicine, and how they relate to patient characteristics and COVID-19 outcomes.
BibTeX
@misc{salerno2020understanding,
author = {Stephen Salerno and Zhangchen Zhao and Swaraaj Prabhu Sankar and Maxwell Salvatore and Tian Gu and Lars G. Fritsche and Seunggeun Lee and Lynda D. Lisabeth and Thomas S. Valley and Bhramar Mukherjee},
title = {{Understanding the patterns of repeated testing for COVID-19: Association with patient characteristics and outcomes}},
year = {2020},
doi = {10.1101/2020.07.26.20162453},
howpublished = {medRxiv},
}